Human Papilloma Virus (HPV) induced chronic diseases have been a huge burden on health system; developing and developed nations equally affected. Among these
diseases cervical cancer is the frontrunner malignancy. More than half a million women are diagnosed with cervical cancer worldwide each year with equally threatening
mortality figures. Evidence of being HPV in the causal pathway of other cancers like anal and laryngeal cancers has also been generated in the recent path. Like all infectious diseases, these diseases can also be contained employing strategies recommended and proven beneficial for other ailments of infectious origin. In addition the availability of a safe yet efficacious vaccine equips us better to counteract against the HPV linked diseases. However, there are certain conflicting and controversial things like financial implications, adverse effects in few scenarios which disfavor the generalization of vaccines resulting into much dreaded vaccine hesitancy. However it is high time for the nations, stakeholders and health managers to evaluate the pros and cons scientifically and decide accordingly in public interest; ending this debate for once and all.
Dr. Ankit Chaudhary